NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Regenerative Medicine Minnesota

Regenerative Medicine Minnesota

Overview

Regenerative Medicine Minnesota is a state-funded initiative that provides grants to advance regenerative medicine research, clinical translation, and biobusiness development throughout Minnesota.

Year Founded

2014

Portfolio Companies

5

Investments

Regenerative Medicine Minnesota investments
CompanyDateStageLead
Anatomic IncorporatedOct 2024GrantCo-investor
Quench MedicalJul 2024GrantLead
Quench MedicalMay 2024GrantLead
LEAH LabsJul 2019GrantCo-investor
Mill Creek Life SciencesJun 2019GrantLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMinnesota
Year Founded2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.